摘要
现代中药组分配伍规律的研究作为一项复杂的系统工程,是以中国传统医学和现代医学理论相结合的学术思想为指导,是整合调节与靶向效应相融合发展的趋势。冠心病心绞痛是最常见的心血管疾病,中药方剂有效部位(群)经组分配伍而创制的新药制剂在防治冠心病心绞痛方面发挥了重要作用,有关临床与实验研究相继取得了重要进展。组分配伍在时代科技与疾病谱的机遇下,基于中医药继承与创新的导向,朝向构建完善成熟的组分中药学学科体系发展。
The research of modern Chinese herbal components compatibility is a complex systems engineering,based on the academic theories of combination of traditional Chinese medicine（TCM）and modern medicine as a guide,which is the development trend of integration of overall regulation and targeting effect.Angina pectoris is one of the most types of cardiovascular diseases,new drugs created by combination of the effective components of Chinese herbal medicines play an important role in the prevention and treatment of angina pectoris.There are many progresses in the clinical and experimental studies about treatment of angina pectoris through the way of components compatibility.The components compatibility are in the era of modern diseases,sciences and technology,based on the inheritance and innovation of TCM,and towards to found a system science in future.
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2010年第6期922-926,共5页
China Journal of Traditional Chinese Medicine and Pharmacy
基金
国家重点基础研究发展计划"973"项目(No.2003CB517103)~~
关键词
现代中药
组分配伍
冠心病心绞痛
综述
Modern Chinese herbal medicines
Components compatibility
Angina pectoris
Review
